To review the evidence linking periodontal disease with atherosclerotic cardiovascular disease (ASCVD) and update findings from a 2012 AHA report, highlighting the importance of these updates in the context of recent research advancements.
Key Findings:
ASCVD is the leading cause of death globally, with periodontal disease affecting 42% of U.S. adults aged 30 and older, including 7.8% with severe disease.
Shared risk factors include older age, smoking, diabetes, hypertension, obesity, and lower socioeconomic status, with specific statistics provided.
Direct mechanisms include bacteremia and vascular infection; indirect mechanisms involve systemic inflammation, with examples of inflammatory markers.
Epidemiologic studies show associations between periodontal disease and various cardiovascular outcomes, including specific conditions.
Interventional studies yield inconclusive results regarding the impact of periodontal treatment on ASCVD events, with examples of intermediate outcomes.
Interpretation:
While substantial evidence supports an association between periodontal disease and ASCVD, a definitive causal relationship has not been established, underscoring the urgent need for further research.
Limitations:
Methodological differences and limited statistical power in studies, which may affect the reliability of findings.
Inconclusive results from interventional studies on cardiovascular outcomes, highlighting the need for more robust research.
Conclusion:
Further research is needed to clarify causality and clinical implications, including longitudinal studies, randomized clinical trials, and specific mechanistic investigations.
